Contract Manufacturing Market Size, Share, Growth, and Industry Analysis, By Type (Medical Device Manufacturing, Pharmaceutical Products Manufacturing), By Application (SMBs, Large Business), Regional Insights and Forecast to 2035

Contract Manufacturing Market Overview

The global Contract Manufacturing Market size estimated at USD 218699.99 million in 2026 and is projected to reach USD 463370.88 million by 2035, growing at a CAGR of 8.7% from 2026 to 2035.

The Contract Manufacturing Market Market is expanding as pharmaceutical companies, biotechnology firms, medicaldevice OEMs, and healthcare startups increasingly outsource specialized production. Pharmaceutical products manufacturing represented 59.8% of North America's contract manufacturing market in 2024, demonstrating the importance of drug manufacturing within outsourced healthcare production. The U.S. accounted for 69.2% of North America's contract manufacturing market in 2024. Medicaldevice manufacturing is also becoming more technically demanding, with Class II devices representing 71.15% of AsiaPacific medicaldevice contract manufacturing in 2024. Contract manufacturers increasingly provide design, prototyping, tooling, assembly, sterilization, packaging, quality management, and supplychain services.

The U.S. remains a major center for healthcare contract manufacturing because of its established pharmaceutical, biotechnology, and medicaldevice ecosystem. The country represented 69.2% of North America's contract manufacturing market in 2024. Pharmaceutical products manufacturing accounted for 59.8% of the regional market during the same year, supported by outsourcing among pharmaceutical and biopharmaceutical companies. Contract manufacturers also benefit from FDAregulated production, ISO 13485certified facilities, advanced automation, precision machining, cleanroom assembly, and specialized drugdevelopment capabilities. Jabil, for example, operates healthcare manufacturing facilities across multiple U.S. locations and maintains FDAregistered facilities for finished medical devices.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Pharmaceutical outsourcing represented 59.8% of North America's contract manufacturing market in 2024, while 78.3% represented pharmaceutical share of healthcare contract manufacturing in 2025, confirming outsourcing as a central production strategy.

• Major Market Restraint: 73% of healthcare OEM respondents identified complex product architectures as a major manufacturing challenge in 2024, while 28% of respondents represented the remaining share, highlighting technical complexity as a measurable outsourcing constraint.

• Emerging Trends: 93% of healthcare survey respondents identified WiFi as an important connectivity technology in 2024, 59% identified Bluetooth, and 98% agreed that AI and machine learning would transform healthcare manufacturing and product development.

• Regional Leadership: 69.2% represented the U.S. share of North America's contract manufacturing market in 2024, while pharmaceutical products manufacturing represented 59.8%, establishing North America as a strong outsourcing center.

• Competitive Landscape: The top 5 medicaldevice contract manufacturers collectively represented approximately 15% of global market share according to published industry estimates, with Jabil, Flex, Integer, Plexus, and Sanmina among the leading participants.

• Market Segmentation: Pharmaceutical products manufacturing represented 58.4% of AsiaPacific contract manufacturing in 2024, while Class II devices represented 71.15% of AsiaPacific medicaldevice contract manufacturing, demonstrating strong demand for regulated production.

• Recent Development: 72% of healthcare respondents expected manufacturing partners to assist with changing technology, supplier, and regulatory requirements in 2024, reinforcing the strategic importance of outsourced manufacturing relationships.

Contract Manufacturing Market Latest Trends

The latest Contract Manufacturing Market Market trends are centered on integrated manufacturing, regulatory specialization, digitalization, and flexible capacity. Pharmaceutical and medicaldevice OEMs increasingly prefer contract manufacturers that can combine engineering, sourcing, production, testing, packaging, and postmarket support within a single relationship. In 2024, 73% of healthcare OEM respondents identified complex product architectures as a major manufacturing challenge, creating demand for technically capable outsourcing partners.Connected medical devices are another important trend. WiFi was identified by 93% of respondents as an important connectivity technology, while Bluetooth was selected by 59%.

AI and machine learning are also becoming manufacturing priorities, with 98% of surveyed respondents agreeing that these technologies could transform healthcare. This is encouraging contract manufacturers to strengthen electronics integration, sensor assembly, softwareenabled testing, data analytics, and automated inspection.Pharmaceutical contract manufacturing is also moving toward integrated CDMO models. Jabil's February 2025 acquisition of Pharmaceutics International added more than 360,000 square feet across 4 sites, more than 70 manufacturing rooms, aseptic manufacturing, lyophilization, oral soliddose manufacturing, formulation development, analytical laboratories, and microbiology capabilities.

Contract Manufacturing Market Dynamics

DRIVER

Rising pharmaceutical and medicaldevice outsourcing

Outsourcing is becoming an important manufacturing strategy because healthcare companies need specialized production capabilities without building every process internally. North America's pharmaceutical products manufacturing segment represented 59.8% of the regional contract manufacturing market in 2024. Pharmaceutical companies increasingly use contract manufacturers for formulation, active pharmaceutical ingredient production, fillfinish operations, packaging, quality control, and commercial manufacturing. Medicaldevice companies similarly outsource precision machining, molding, electronics assembly, sterilization, and finisheddevice assembly.The complexity of healthcare products further strengthens this driver. Jabil reported that most medical devices produced within its healthcare operations now incorporate electronics and communications technology, requiring specialized engineering and manufacturing expertise.

RESTRAINT

Increasing regulatory and manufacturing complexity

Regulatory compliance is a major restraint because contract manufacturers operating in healthcare must maintain highly controlled production environments, validated processes, traceability, quality documentation, and regulatory certifications. Jabil's healthcare quality systems include ISO 13485, ISO 14971, 21 CFR Part 820, 21 CFR Part 11, and other standards across applicable manufacturing locations. Maintaining these systems requires specialized personnel, validated equipment, documentation controls, and continuous auditing.Product complexity also increases manufacturing risk. In a 2024 healthcare survey, 73% of respondents identified complex product architectures as a major manufacturing challenge. Connected devices require electronics, sensors, software interfaces, communication technologies, and mechanical components to operate together reliably.

OPPORTUNITY

Expansion of integrated endtoend manufacturing services

The strongest opportunity is the transition from individual production services toward integrated contract manufacturing platforms. Pharmaceutical customers increasingly require development, formulation, clinical manufacturing, commercial production, fillfinish, packaging, and analytical services from coordinated partners. Medicaldevice customers similarly seek designformanufacturing, prototyping, tooling, component production, assembly, sterilization, packaging, and postmarket support.Jabil's 2025 acquisition of Pharmaceutics International illustrates this direction. Pii contributed more than 360,000 square feet of facilities across 4 sites, more than 70 manufacturing rooms, aseptic capabilities, oral soliddose manufacturing, formulation development, and analytical and microbiology laboratories. This creates an opportunity for contract manufacturers to capture more stages of the healthcare product lifecycle.Another opportunity comes from advanced medicaldevice technologies.

CHALLENGE

Balancing scale, quality, flexibility, and supplychain resilience

Contract manufacturers face the difficult task of maintaining high utilization while retaining sufficient flexibility for new product introductions, engineering changes, demand fluctuations, and emergency production requirements. Healthcare products are subject to stringent quality requirements, making rapid process changes more complicated than in many consumer manufacturing categories.Digital medical devices create an additional challenge because manufacturing increasingly combines mechanical, electronic, software, and connectivity requirements. In 2024, 93% of surveyed healthcare respondents identified WiFi as an important connectivity technology and 59% identified Bluetooth. AI and machine learning were viewed as transformational by 98% of respondents. Manufacturers must therefore invest in electronics integration, automated testing, cybersecurityrelated controls, data management, and skilled engineering teams.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Segmentation Analysis

The Contract Manufacturing Market Market is segmented primarily by type and application, with pharmaceutical products manufacturing and medicaldevice manufacturing representing the principal production categories. Pharmaceutical products manufacturing held a 59.8% share of North America's market in 2024 and a 58.4% share in AsiaPacific during the same year. Application segmentation distinguishes SMBs from large businesses, reflecting different outsourcing requirements, production volumes, capital resources, and regulatory capabilities.

By Type

Medical Device Manufacturing

Medical Device Manufacturing is a major Contract Manufacturing Market Market segment because medicaldevice OEMs increasingly outsource precision production, component manufacturing, assembly, sterilization, packaging, and testing. AsiaPacific Class II devices represented 71.15% of the medicaldevice contract manufacturing market in 2024, indicating strong demand for mediumrisk regulated devices.Medicaldevice contract manufacturers serve cardiovascular, orthopedic, neurological, diagnostic, respiratory, ophthalmic, urological, surgical, and drugdelivery applications. Jabil's capabilities include complex catheter assemblies, micro molding, micro assembly, sensor integration, roboticassisted surgical systems, electrical testing, calibration, and sterilization. Integer operates more than 2.5 million square feet of manufacturing space and focuses on Class II and Class III device production.

Pharmaceutical Products Manufacturing

Pharmaceutical Products Manufacturing represents the largest type segment in several regional assessments. It accounted for 59.8% of North America's contract manufacturing market in 2024 and 58.4% of AsiaPacific's market during the same year. Pharmaceutical outsourcing encompasses active pharmaceutical ingredients, formulations, oral solid doses, sterile injectables, fillfinish operations, packaging, analytical testing, and clinical manufacturing.The segment is increasingly influenced by biologics, complex injectable products, specialty medicines, and drugdelivery technologies. Contract manufacturers are investing in aseptic processing, containment suites, lyophilization, analytical laboratories, and automated packaging. Jabil's acquisition of Pii in February 2025 added more than 70 manufacturing rooms and capabilities spanning aseptic injectables, oral products, formulation development, analytical testing, and microbiology.

By Application

SMBs

Small and mediumsized businesses represent an important Contract Manufacturing Market Market application because smaller pharmaceutical, biotechnology, and medicaldevice companies often have limited internal manufacturing infrastructure. Contract manufacturing allows these businesses to access specialized facilities, validated processes, engineering expertise, and regulated production without establishing complete manufacturing networks.SMBs particularly benefit from prototype manufacturing, smallbatch production, clinicalstage manufacturing, specialized packaging, and production scaleup. The need is especially significant for medicaldevice startups developing complex Class II and Class III technologies. Contract manufacturers can provide designformanufacturing support, tooling, testing, assembly, sterilization, and regulatory documentation.

Large Business

Large businesses represent a major application segment because multinational pharmaceutical and medicaldevice companies increasingly use contract manufacturers to supplement internal capacity, access specialized technology, and create geographic manufacturing flexibility. Large enterprises can outsource individual processes while retaining control over product design, intellectual property, regulatory strategy, and commercialization.The scale of largebusiness outsourcing is visible in Jabil's healthcare operations, where the company reports more than 200,000 expert manufacturers globally and a supplier ecosystem involving more than 36,000 suppliers. Such scale enables customers to access procurement, engineering, manufacturing, quality, and logistics capabilities through a single manufacturing partner.Large businesses are also driving demand for integrated services. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Contract Manufacturing Market Regional Outlook

The regional Contract Manufacturing Market Market is shaped by pharmaceutical outsourcing, medicaldevice production, regulatory infrastructure, skilled manufacturing labor, technology availability, and supplychain ecosystems. North America remains a major established market, while AsiaPacific combines large pharmaceutical production bases with expanding medicaldevice manufacturing. Europe benefits from advanced engineering and regulated healthcare manufacturing, while Middle East & Africa presents opportunities through healthcare infrastructure development and localized production initiatives. AsiaPacific pharmaceutical products manufacturing represented 58.4% of its contract manufacturing market in 2024, while North American pharmaceutical manufacturing represented 59.8%.

North America

North America is a leading Contract Manufacturing Market Market region because it combines mature pharmaceutical companies, biotechnology clusters, medicaldevice manufacturers, specialized suppliers, advanced regulatory infrastructure, and established contract manufacturing organizations. The U.S. accounted for 69.2% of North America's contract manufacturing market in 2024, making it the dominant country in the regional market. Pharmaceutical products manufacturing represented 59.8% of the regional market during the same year.The U.S. market is particularly strong in pharmaceutical development, biologics manufacturing, sterile production, medicaldevice assembly, precision machining, and advanced electronics. Contract manufacturers increasingly support connected medical devices, minimally invasive surgical instruments, cardiovascular devices, diagnostic equipment, and drugdelivery systems.Jabil illustrates the depth of the U.S. manufacturing ecosystem.

Europe

Europe remains an important Contract Manufacturing Market Market because of its advanced pharmaceutical sector, sophisticated medicaldevice ecosystem, engineering capabilities, and strong regulatory framework. European contract manufacturers serve pharmaceutical companies, biotechnology firms, diagnostics developers, and medicaldevice OEMs requiring precision production and highquality manufacturing.The European market is particularly relevant to sterile pharmaceutical manufacturing, specialty medicines, biologics, drugdelivery devices, and advanced medical equipment. Contract manufacturing operations increasingly integrate automated production, electronic quality systems, cleanroom technologies, and sophisticated inspection processes.Ireland, Germany, Switzerland, the United Kingdom, France, and Italy represent important manufacturing locations. 

AsiaPacific

AsiaPacific is one of the most important growth centers for contract manufacturing because of its pharmaceutical production capacity, expanding medicaldevice industry, manufacturing workforce, improving regulatory infrastructure, and strong supplier networks. Pharmaceutical products manufacturing accounted for 58.4% of AsiaPacific's contract manufacturing market in 2024. Within AsiaPacific medicaldevice contract manufacturing, Class II devices represented 71.15% of the market in 2024.China, India, Japan, South Korea, Singapore, and Thailand each contribute different manufacturing strengths. India is particularly important for pharmaceutical manufacturing and generic medicines, while China provides extensive component, electronics, medicaldevice, and pharmaceutical production capabilities. Japan contributes precision manufacturing and highquality medical technologies, while South Korea has expanded capabilities in biologics and advanced healthcare production.

Middle East & Africa

The Middle East & Africa represents an emerging Contract Manufacturing Market Market opportunity driven by healthcare infrastructure development, pharmaceutical localization, medicaldevice demand, and efforts to improve regional supplychain resilience. Contract manufacturing can support local pharmaceutical production by providing formulation, packaging, quality control, and specialized manufacturing capabilities without requiring every healthcare company to establish a complete production infrastructure.Countries including Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and Turkey have developed pharmaceutical and healthcare manufacturing ecosystems. Regional manufacturers are increasingly interested in partnerships involving generic medicines, sterile products, medical consumables, diagnostics, and healthcare equipment.The opportunity is especially relevant to pharmaceutical localization because manufacturing partnerships can shorten supply chains and support local availability.

List of Top Contract Manufacturing Market Companies

• Integer Holdings Corp.
• Sanmina Corp.
• Synecco Ltd.
• Viant
• Cantel Medical Corp.
• Celestica
• Tecomet INC
• Jabil
• West Pharmaceutical Services
• Angiplast Pvt. Ltd.
• Plexus Corp.
• Flex Ltd.

List of Top tow Companies Market Share

• Flex Ltd. – 28.7%: A published medicaldevice contract manufacturing estimate places Flex at 28.7% market share, making it the highestranked company in that specific marketshare assessment. Its competitive position is supported by global manufacturing, engineering, supplychain, and healthcare production capabilities.

• Jabil, Inc. – 19.8%: The same published assessment places Jabil at 19.8% market share, ranking it second. Jabil maintains more than 30 ISO 13485certified medicaldevice manufacturing sites and provides manufacturing across medical devices, diagnostics, pharmaceutical delivery systems, and healthcare electronics.

Investment Analysis and Opportunities

Investment activity in the Contract Manufacturing Market Market is increasingly directed toward specialized capacity, automation, cleanroom infrastructure, pharmaceutical CDMO capabilities, advanced medicaldevice production, sterilization, and vertically integrated supply chains. The strategic priority is shifting from adding basic production capacity toward acquiring technologies that allow manufacturers to support complex products from development through commercial production.Jabil's acquisition of Pharmaceutics International in February 2025 is a significant example. The transaction added more than 360,000 square feet across 4 sites, more than 70 manufacturing rooms, aseptic facilities, oral soliddose manufacturing, formulation development, analytical laboratories, and microbiology capabilities.

Integer's acquisition of Pulse Technologies also illustrates investment in specialized medicaldevice manufacturing. The transaction added complex micromachining, advanced surface technologies, titanium nitride coatings, and 250 employees, strengthening Integer's position in cardiovascular and neuromodulation manufacturing.Future investment opportunities include automated inspection, robotics, AIsupported production monitoring, digital quality systems, advanced catheter manufacturing, micro molding, precision machining, sterile fillfinish, lyophilization, and connecteddevice assembly. Contract manufacturers that combine these capabilities with global supplychain management can capture outsourcing demand from both emerging companies and multinational healthcare OEMs.

New Product Development

New product development within the Contract Manufacturing Market Market is increasingly focused on connected medical devices, minimally invasive technologies, advanced drugdelivery systems, precision components, and digitally enabled pharmaceutical manufacturing. Product development is no longer limited to physical manufacturing; contract manufacturers increasingly participate in designformanufacturing, prototyping, validation, engineering transfer, testing, and commercial scaleup.Jabil's medicaldevice capabilities include complex catheters, disposable endoscopes, roboticassisted surgical systems, micro molding, micro assembly, sensor integration, advanced optical assembly, and electrical testing. The company has also invested in an Advanced Catheter Development Lab to accelerate prototype development.

Connected healthcare products are another major innovation area. In 2024, 93% of surveyed healthcare respondents identified WiFi as an important connectivity technology and 59% identified Bluetooth. AI and machine learning received support from 98% of respondents as technologies capable of transforming healthcare. These figures are encouraging contract manufacturers to develop manufacturing processes capable of integrating sensors, electronics, communication modules, and softwareenabled functionality.Pharmaceutical product development is also becoming more integrated. Jabil's acquisition of Pii added aseptic fillfinish, lyophilization, oral soliddose production, formulation development, analytical testing, and microbiology, strengthening the ability to move pharmaceutical products from development through commercial manufacturing.

Five Recent Developments (20232025)

• January 2024: Integer Holdings Corporation acquired Pulse Technologies. Integer completed the acquisition on January 5, 2024, adding a contract manufacturing company specializing in complex micromachining for structural heart, heart pump, electrophysiology, leadless pacing, and neuromodulation applications. Pulse added 250 associates and technologies including Hierarchical Surface Restructuring, scratchfree surface finishing, and titanium nitride coatings.
• October 2024: Jabil acquired Mikros Technologies. Jabil completed the acquisition on October 1, 2024, adding engineering and manufacturing expertise in liquidcooling systems. The transaction strengthened Jabil's capabilities for highpowerdensity systems and demonstrated its strategy of expanding specialized manufacturing technologies alongside its broader global production platform.
• December 2024: Jabil published its healthcare manufacturing survey findings. The 2024 survey reported that 73% of respondents considered complex product architectures a major manufacturing challenge, 93% identified WiFi as an important connectivity technology, 59% identified Bluetooth, and 98% expected AI and machine learning to transform healthcare.
• February 2025: Jabil acquired Pharmaceutics International, Inc. Jabil completed the acquisition on February 3, 2025. Pii contributed more than 360,000 square feet across 4 sites, more than 70 manufacturing rooms, aseptic manufacturing, lyophilization, oral soliddose production, formulation development, analytical testing, and microbiology capabilities, strengthening Jabil's pharmaceutical contract manufacturing platform.
• May 2025: Sanmina announced an agreement to acquire the ZT Systems datacenter infrastructure manufacturing business from AMD. The announced transaction was valued at up to $3 billion and included a planned strategic relationship under which Sanmina would become a preferred newproductintroduction manufacturing partner for AMD's rackscale and clusterscale AI solutions. The transaction demonstrated the growing importance of advanced manufacturing and NPI capabilities.

Report Coverage of Contract Manufacturing Market

The Contract Manufacturing Market Market report covers outsourced manufacturing activities serving pharmaceutical products and medical devices, with analysis by manufacturing type, business application, geography, competitive landscape, investment activity, innovation, and recent developments. The report focuses on Medical Device Manufacturing and Pharmaceutical Products Manufacturing as the principal type categories and SMBs and Large Business as the primary application categories.Regional coverage includes North America, Europe, AsiaPacific, and Middle East & Africa, with specific attention to manufacturing infrastructure, outsourcing intensity, regulatory requirements, technology adoption, and competitive positioning. North America analysis includes the U.S. position, where the country represented 69.2% of North America's contract manufacturing market in 2024.

The competitive section covers 12 specified companies: Integer Holdings Corp., Sanmina Corp., Synecco Ltd., Viant, Inc., Cantel Medical Corp., Celestica, Inc., Tecomet INC, Jabil, Inc., West Pharmaceutical Services, Inc., Angiplast Pvt. Ltd., Plexus Corp., and Flex Ltd. The report also examines leading company positioning, manufacturing capabilities, specialized technologies, acquisitions, capacity expansion, product development, and strategic partnerships.The scope further evaluates digital manufacturing, connected healthcare, automation, AIsupported production, precision machining, cleanroom manufacturing, sterilization, pharmaceutical fillfinish, advanced drug delivery, and medicaldevice assembly. Particular attention is given to measurable indicators such as the 73% complexarchitecture challenge rate, 98% AI/ML transformation expectation, and 72% expectation for manufacturing partners to support changing technology and regulatory requirements.

Contract Manufacturing Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 218699.99 Billion in 2026
Market Size Value By	USD 463370.88 Billion by 2035
Growth Rate	CAGR of 8.7% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Medical Device Manufacturing Pharmaceutical Products Manufacturing By Application : SMBs Large Business
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample